NCT06250075View on ClinicalTrials.gov

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 12, 2020

Primary Completion Date

August 4, 2022

Study Completion Date

April 26, 2024

Conditions

Gastric AdenocarcinomaGastric CancerMicrobiomeCytokinesNutritional Status

Interventions

DIETARY_SUPPLEMENT

Formulation with probiotics

Lactobacillus acidophilus NCFM®, Lactobacillus paracasei Lpc-37 ™, Bifidobacterium lactis Bi-04™, Bifidobacterium lactis Bi-07™, Bifidobacterium bifidum Bb-02™)

OTHER

Non-intervention for Clinical Outcomes -G5

only observation of clinical outcomes in the postoperative period

Trial Locations (1)

69043160

Abner Souza Paz, Manaus

All Listed Sponsors

lead

Universidade Federal do Amazonas

OTHER

NCT06250075 - Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer | Biotech Hunter | Biotech Hunter